After finishing at $33.50 in the prior trading day, Tandem Diabetes Care Inc (NASDAQ: TNDM) closed at $31.86, down -4.90%. On the day, 1111875 shares were traded.
Ratios:
Our goal is to gain a better understanding of TNDM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.02 and its Current Ratio is at 3.83. In the meantime, Its Debt-to-Equity ratio is 1.33 whereas as Long-Term Debt/Eq ratio is at 1.27.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on March 26, 2024, Upgraded its rating to Buy and sets its target price to $37 from $24 previously.
On August 04, 2023, Citigroup Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $45 to $33.
BofA Securities Downgraded its Neutral to Underperform on May 05, 2023, whereas the target price for the stock was revised from $45 to $33.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 27 ’23 when Allen Dick bought 5,000 shares for $18.96 per share. The transaction valued at 94,778 led to the insider holds 19,962 shares of the business.
Vosseller Leigh bought 6,200 shares of TNDM for $95,395 on Nov 08 ’23. The EVP & CHIEF FINANCIAL OFFICER now owns 11,860 shares after completing the transaction at $15.39 per share. On Nov 08 ’23, another insider, Hansen Shannon Marie, who serves as the Chief Legal Officer of the company, bought 1,935 shares for $15.44 each. As a result, the insider paid 29,884 and bolstered with 1,935 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.75 while its Price-to-Book (P/B) ratio in mrq is 6.66.
Stock Price History:
Over the past 52 weeks, TNDM has reached a high of $42.40, while it has fallen to a 52-week low of $13.82.
Shares Statistics:
A total of 65.55M shares are outstanding, with a floating share count of 64.13M. Insiders hold about 0.68% of the company’s shares, while institutions hold 110.58% stake in the company.
Earnings Estimates
Its stock is currently analyzed by Nano Dimension Ltd. different market analysts. The consensus estimate for the next quarter is $31.86, with high estimates of $50.35 and low estimates of $0.05.
EPS for the following year is $Stocks, with Stocks analysts recommending between $ETF and $Stocks.
